about
Heparin affin regulatory peptide/pleiotrophin negatively affects diverse biological activities in C6 glioma cellsExpression of macrophage elastase (MMP12) in rat tail intervertebral disc and growth plate after asymmetric loading.Evidence that platelets promote tube formation by endothelial cells on matrigel.Heparin affin regulatory peptide: a new target for tumour therapy?Interplay between αvβ3 integrin and nucleolin regulates human endothelial and glioma cell migration.Measurement of cell numbers in microtiter culture plates using the fluorescent dye Hoechst 33258.Roles of pleiotrophin in tumor growth and angiogenesis.Cell surface nucleolin as a target for anti-cancer therapies.Chondroitin sulfate-cell membrane effectors as regulators of growth factor-mediated vascular and cancer cell migration.Synthesis of nοvel artemisinin dimers with polyamine linkers and evaluation of their potential as anticancer agents.Vascular endothelial growth factor A (VEGF-A) decreases expression and secretion of pleiotrophin in a VEGF receptor-independent manner.Pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta as regulators of angiogenesis and cancer.Epidermal growth factor receptor status and Notch inhibition in non-small cell lung cancer cellsReceptor protein tyrosine phosphatase beta/zeta is a functional binding partner for vascular endothelial growth factorPleiotrophin-induced endothelial cell migration is regulated by xanthine oxidase-mediated generation of reactive oxygen species.Effect of an all-trans-retinoic acid conjugate with spermine on viability of human prostate cancer and endothelial cells in vitro and angiogenesis in vivo.Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo.Pyrrolo[2,3-α]carbazole derivatives as topoisomerase I inhibitors that affect viability of glioma and endothelial cells in vitro and angiogenesis in vivo.Effect of conjugates of all-trans-retinoic acid and shorter polyene chain analogues with amino acids on prostate cancer cell growth.Nitric oxide stimulates migration of human endothelial and prostate cancer cells through up-regulation of pleiotrophin expression and its receptor protein tyrosine phosphatase beta/zeta.Irradiated C6 glioma cells induce angiogenesis in vivo and activate endothelial cells in vitro.The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.Transauricular balloon angioplasty in rabbit thoracic aorta: a novel model of experimental restenosis.Nitration of cytoskeletal proteins in the chicken embryo chorioallantoic membrane.Amifostine inhibits angiogenesis in vivo.A peptide corresponding to the C-terminal region of pleiotrophin inhibits angiogenesis in vivo and in vitro.Amifostine has antiangiogenic properties in vitro by changing the redox status of human endothelial cells.Perillyl alcohol is an angiogenesis inhibitor.Antioxidants inhibit angiogenesis in vivo through down-regulation of nitric oxide synthase expression and activity.Effects of retinoic acid steroidal analogs on human leukemic HL60 cell proliferation in vitro and on angiogenesis in vivo.Integrin alpha(v)beta(3) is a pleiotrophin receptor required for pleiotrophin-induced endothelial cell migration through receptor protein tyrosine phosphatase beta/zeta.Inhibition of Atherosclerosis Progression, Intimal Hyperplasia, and Oxidative Stress by Simvastatin and Ivabradine May Reduce Thoracic Aorta's Stiffness in Hypercholesterolemic Rabbits.Αnaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options.Effects of mechanical loading on the expression of pleiotrophin and its receptor protein tyrosine phosphatase beta/zeta in a rat spinal deformity model.A minimally invasive endovascular rabbit model for experimental induction of progressive myocardial hypertrophy.Cyclin-dependent kinase 5 mediates pleiotrophin-induced endothelial cell migration.Synthesis and evaluation of condensed magnetic nanocrystal clusters with in vivo multispectral optoacoustic tomography for tumour targeting.Donor lung pretreatment with surfactant in experimental transplantation preserves graft hemodynamics and alveolar morphology.X-rays modulate extracellular matrix in vivo.Soluble guanylyl cyclase activation promotes angiogenesis
P50
Q28575578-3499665D-231D-43AF-A153-15B9DD65DDA2Q34259316-515765BD-697B-4A1D-BDD1-2FDC033F25DCQ35028157-22932D56-BD70-4EBB-91B1-F0F1EDF7A166Q35892757-08FF18A9-027E-46A9-8E59-E7874CC97CB0Q36508636-8262DC02-60D3-46E8-9DDA-9165EE760500Q36696106-7F303129-1FB2-4296-AC5D-3E87127E1D0FQ37694877-F07658DC-4EBF-4284-9A2B-B6FA7F1BB185Q38164097-3841B379-89D5-4D28-945C-7874AE275291Q38177514-3D782B1F-28B2-4FC8-B985-938D47BB7C6DQ38760871-7A636552-0E28-408C-AAF2-61E85A24529EQ38790301-081E7FB6-DA93-4CFC-82CA-3C10E01FA539Q38807278-E43CD0A6-08F4-48D8-8CB0-A743B7C5DC61Q38825333-FF96DAD8-BFFC-4F37-96B8-B2F2A99703A3Q38913862-A81443C6-23F8-442C-BC65-BB6ADC4DCE01Q38920693-78B0621F-D73B-4F23-9FFD-5193E08B5847Q39239524-5A5C7C6B-6944-4705-A1DB-8F8E93B9798BQ39316539-1CD34D3A-182F-4705-9992-7ACC36145A44Q39535739-8E2E3F01-020A-409D-9BE7-0A0640A0C55FQ39859521-B4B3FD1D-F076-478E-942F-373ECA43484EQ39908522-519EAE38-75B9-4A81-8A05-04B8006CD4D1Q40550591-627116D9-9AB0-4CC9-997C-A01BF288A1FDQ40683670-4B95391A-37F6-491C-B091-E63BA2292C0CQ41962479-B81F7B69-DECB-43BA-ACB0-98DE13F19B78Q44020609-0362612D-2B31-4851-9EC7-926F70567CFFQ44285561-05380D34-DBF2-4EE5-A007-32D3D7A9788CQ44381486-AF8DBC48-C06A-470A-A616-5BE3869B3ABFQ44711962-D2A71FC4-815C-4078-99B6-1CCD0C2ABDAFQ44947192-83273740-80DD-41FE-B307-49F1A83A79C6Q45006846-6FE19A49-7F1F-4D62-9034-11B47C4AF83CQ45227927-A2F860AB-0C25-489E-BB04-6E68B510D196Q45904605-F49BBD05-BF5A-4233-B489-80B95B67A6B7Q46632831-FA6231C1-ED1A-49DB-8EC6-5F9317E921FBQ47863118-D17822DA-D63E-4DF4-94B1-20FE4F1B273BQ51626337-79F47F81-85D7-4577-A605-05A282D52F31Q51687887-E96A6A8F-E81F-4D8B-9FF6-45DD97C809B0Q52590942-9208BC4F-C429-4301-8E4C-92F63C1CC5EEQ52983926-77075B72-F6F4-401C-8D51-2E1DF89AF3DCQ53932951-ADA14AF5-7DB9-44F8-8CDA-B5D4D8C6A11DQ55473894-8A57DF8B-0F4B-4ABD-BF0E-D4979C70A770Q64377535-33F530FF-0EED-4AFC-A7EA-1AC61EC0CDA2
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Evangelia Papadimitriou
@ast
Evangelia Papadimitriou
@en
Evangelia Papadimitriou
@es
Evangelia Papadimitriou
@nl
type
label
Evangelia Papadimitriou
@ast
Evangelia Papadimitriou
@en
Evangelia Papadimitriou
@es
Evangelia Papadimitriou
@nl
prefLabel
Evangelia Papadimitriou
@ast
Evangelia Papadimitriou
@en
Evangelia Papadimitriou
@es
Evangelia Papadimitriou
@nl
P1153
36834915600
57202675946
P31
P496
0000-0001-6429-4325